Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus

Vaccine

Volumn 18, Issue 7-8, 1999, Pages 588-596

  Bennett, Alice M ^a   Phillpotts, Robert J ^a   Perkins, Stuart D ^a   Jacobs, Susan C ^a   Williamson, E Diane ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

DNA immunisation; Plague; VEE

Indexed keywords

BACTERIAL ANTIGEN; DNA VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; PLASMID DNA; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; ENCEPHALITIS VIRUS; ENCEPHALOMYELITIS; GENE GUN; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION; YERSINIA PESTIS;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; BIOLISTICS; CHILD, PRESCHOOL; DNA; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; FEMALE; GOLD; HUMANS; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; PLASMIDS; PORE FORMING CYTOTOXIC PROTEINS; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; YERSINIA PESTIS;

EID: 0032736438     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00317-5     Document Type: Article

References (38)

1. Jones D.H., Corris S., McDonald S., Clegg J.C.S., Farrrar G.H. Poly(D,L-lactide-co-glycolide)-encapsulated plamid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine. 15:1997;814-817.
2. Alpar H.O., Ozsoy Y., Bowen J., Eyles J.E., Conway B.R., Williamson E.D. Potential of particulate carriers for the mucosal delivery of DNA vaccines. Biochem. Soc. Trans. 25:1997;3375.
3. Gregoriadis G., Saffie R., de Souza B. Liposome-mediated DNA vaccination. FEBS Letters. 402:1997;107-110.
4. Sizemore D., Branstrom A., Sadoff J. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunogenicity. Science. 270:1995;299-302.
5. Darji A., Guzman C.A., Gerstel B., Wachholz P., Timmis K.N., Wehland J., Chakraborty T., Weiss S. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell. 91:1997;765-775.
6. Pardoll D.M., Beckerleg A.M. Exposing the immunology of DNA vaccines. Immunity. 3:1995;165-169.
7. Ertl H.C.J., Xiang Z.Q. Genetic immunization. Viral. Immunol. 9:1996;1-9.
8. Shiver J.W., Ulmer J.B., Donnelly J.J., Liu M.A. Humoral and cellular immunities elicited by DNA vaccines: application to the human immunodeficiency virus and influenza. Adv. Drug Deliv. Rev. 21:1996;19-31.
9. Davis H.L., Mancini M., Michel M.L., Whalen R.G. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine. 14:1996;910-915.
10. Justewicz D.M., Webster R.G. Long-term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization. Virology. 224:1996;10-17.
11. Anderson R., Gao X-M., Papakonstantinopoulou A., Fairweather N., Roberts M., Dougan G. Immunization of mice with DNA encoding fragment C of tetanus toxin. Vaccine. 15:1997;827-829.
12. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal and gene-gun inoculations. Proc. Natl. Acad. Sci. USA. 90:1993;11478-11482.
13. Chang S.W., Bu J., Rompato G., Garmendia A.E. A vector DNA vaccine encoding pseudorabies virus immediate early protein demonstrates partial protection in mice against lethal virus challenge. Viral Immunol. 11:1998;27-36.
14. Barry M.A., Johnston S.A. Biological features of genetic immunization. Vaccine. 15:1997;788-791.
15. Strugnell R.A., Drew D., Mercieca J., DiNatale S., Firez N., Dunstan S.J., Simmons C.P., Vadolas J. DNA vaccines for bacterial infections. Immunol. Cell. Biol. 75:1997;364-369.
16. Williamson E.D., Eley S.M., Griffin K.F., Green M., Russell P., Leary S.E.C., Oyston P.C.F., Easterbrook T., Reddin K.M., Robinson A., Titball R.W. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol. Med. Micro. 12:1995;223-230.
17. Leary S.E.C., Williamson E.D., Griffin K.F., Russell P., Eley S.M., Titball R.W. Active immunisation with recombinant V antigen from Yersinia pestis protects mice against plague. Infect. Immun. 63:1995;2854-2858.
18. Kinney R.M., Esposito J.J., Johnson B.J.B., Roehrig J.T., Mathews J.H., Barrett A.D.T., Trent D.W. Recombinant vaccinia/Venezuelan Equine Encephalitis (VEE) virus expresses VEE structural proteins. J. Gen. Virol. 69:1988;3005-3013.
19. Wilkinson G.W.G., Akrigg A. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucl. Acids Res. 20:1992;2233-2239.
20. Williamson E.D., Titball R.W. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene. Vaccine. 11:1993;1253-1258.
21. Leonard J.M. The arithmetic of decision-making. 1971;The English Universities Press Ltd, London.
22. Williamson E.D., Eley S.M., Stagg A.J., Green M., Russell P., Titball R.W. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine. 15:1997;1079-1084.
23. Kinney R.M., Trent D.W., France J.K. Comparative immunological and biochemical analyses of viruses in the Venezuelan equine encephalitis complex. J. Gen. Virol. 64:1983;135-147.
24. Corr M., Lee D.J., Carson D.A., Tighe H. Gene vaccination with naked plasmid DNA: Mechanism of CTL priming. J. Exp. Med. 184:1996;1555-1560.
25. Robinson H.L. Nucleic acid vaccines: an overview. Vaccine. 15:1997;785-787.
26. Heydenburg Fuller D., Simpson L., Stefano Cole K., Clements J.E., Panicali D.L., Montelaro R.C., Murphey-Corb M., Haynes J. Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors supresses virus burden in rhesus macaques challenged with a heterologous SIV. Immunol. Cell. Biol. 75:1997;389-396.
27. Hanke T., Blanchard T.J., Schneider J., Hannan C.M., Becker M., Gilbert S.C., Hill A.V.S., Smith G.L., McMichael A. Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine. 16:1998;439-445.
28. Leong K.H., Ramsay I.A., Morin J., Robinson H.L., Boyle D.B. Generation of enhanced immune responses by consecutive immunisation with DNA and recombinant fowl pox virus. Brown F., Chanock R., Ginsberg H. Vaccines 95. 1995;327-331 Cold Spring Harbour Laboratory Press, Cold Spring Harbor.
29. Fuller D.H., Murphey-Corb M., Clements J., Barnett S., Haynes J. Induction of immunodeficiency virus-specific immune responses in monkeys following gene gun-mediated DNA vaccination. J. Med. Primatol. 25:1996;236-241.
30. Lu S., Santoro J.C., Fuller D.H., Haynes J.R., Robinson H.L. Use of DNAs expressing HIV-1 particles to raise antibody responses in mice. Virology. 209:1995;147-154.
31. Xiang Z., Ertl H.C.J. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity. 2:1995;129-135.
32. Lewis P.J., Cox G.J.M., van Drunen Littel-van den Hurk S., Babiuk L.A. Polynucleotide vaccines in animals: enhancing and modulating reponses. Vaccine. 15:1997;861-864.
33. Iwasaki A., Stiernholm B.J.N., Chan A.K., Bernstein N.L., Barber B.H. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158:1997;4591-4601.
34. Chun S., Daheshia M., Kuklin N.A., Rouse B.T. Modulation of viral immunoinflammatory responses with cytokine DNA administered by different routes. J. Virol. 72:1998;5545-5551.
35. Yokoyama M., Hassett D.E., Zhang J., Whitton J.L. DNA immunization can stimulate florid local inflammation and the antiviral immunity induced varies depending on injection iste. Vaccine. 15:1997;553-560.
36. Torres C.A.T., Iwasaki A., Barber B.H., Robinson H.L. Differential dependance on target site tissue for gene gun and intramuscular DNA immunizations. J. Immunol. 158:1997;4529-4532.
37. Boyle J.S., Silva A., Brady J.L., Lew A.M. DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity. Proc. Natl. Acad. Sci. 94:1997;14626-14631.
38. Williamson E.D., Vesey P.M., Gillhespy K.J., Eley S.M., Green M., Titball R.W. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin. Exp. Immunol. 116:1999;107-114.